Drug intelligence / Profile preview

HollisterStier allergen extracts

Development stage
Unknown
Lead developer
Jubilant HollisterStier
Modality
Vaccines & Immunotherapeutics
Administration
Intralymphatic
01

Overview

HollisterStier allergen extracts are a combination of standardized and non-standardized biological products used for allergen-specific immunotherapy. In the context of a clinical trial led by Gachon University Gil Medical Center, these extracts—specifically targeting house dust mites (*Dermatophagoides farinae* and *Dermatophagoides pteronyssinus*), cat hair, and dog hair/dander—are administered via intralymphatic immunotherapy (ILIT). This therapeutic approach involves direct injection into the inguinal lymph nodes to induce immunological tolerance more efficiently than traditional subcutaneous methods. The mechanism of action involves modulating the immune system's response to specific allergens by shifting from a Th2-dominated allergic profile to a Th1/Treg-mediated tolerant state. This is characterized by the induction of regulatory T-cells, increased production of protective IgG4 antibodies, and a reduction in the activity of allergen-specific IgE, thereby alleviating the symptoms of allergic rhinitis.

Brand names
HollisterStier
Other names
ILIT allergen extractsHollisterStier allergen-specific intralymphatic immunotherapyDermatophagoides farinae + Dermatophagoides pteronyssinus + cat hair + dog hair extracts
02

Targets

IgE (Immunoglobulin E)

Beyond the preview

Go deeper on HollisterStier allergen extracts.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on HollisterStier allergen extracts.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call